Valeo Financial Advisors’s Assembly Biosciences ASMB Stock Holding History
Bought
Maintained
Sold
Other funds holding ASMB
DTC
AIM
AC
PIM
Valeo Financial Advisors's ASMB Position: Q1 2022 in Review
Valeo Financial Advisors sold out of Assembly Biosciences (ASMB) in Q1 2022, closing a stake of 2,125 shares — an estimated $59K sold.
Valeo Financial Advisors first reported a position in ASMB in Q3 2017 and held it in 16 quarters. The position peaked at $4.96M in Q3 2017. 54 funds tracked by Wall St. Rank hold ASMB as of Q1 2022.
- Valeo Financial Advisors reported no remaining Assembly Biosciences position as of Q1 2022 after selling out during the quarter.
- Valeo Financial Advisors sold 2,125 Assembly Biosciences shares in Q1 2022, an estimated $59K.
- Valeo Financial Advisors first reported a position in Assembly Biosciences in Q3 2017 and held it in 16 quarters.
- Valeo Financial Advisors's Assembly Biosciences position peaked at $4.96M in Q3 2017.
- 54 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2022.
Based on Valeo Financial Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.